167 related articles for article (PubMed ID: 28073696)
1. SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth.
Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW
Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696
[TBL] [Abstract][Full Text] [Related]
2. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
[TBL] [Abstract][Full Text] [Related]
3. SPOP promotes FADD degradation and inhibits NF-κB activity in non-small cell lung cancer.
Luo J; Chen B; Gao CX; Xie HK; Han CN; Zhou CC
Biochem Biophys Res Commun; 2018 Sep; 504(1):289-294. PubMed ID: 30190126
[TBL] [Abstract][Full Text] [Related]
4. SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A.
Xu W; Jiang K; Shen M; Qian Y; Peng Y
Biol Chem; 2015 Aug; 396(8):929-36. PubMed ID: 25719312
[TBL] [Abstract][Full Text] [Related]
5. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
[TBL] [Abstract][Full Text] [Related]
6. Regulation of SIRT2 levels for human non-small cell lung cancer therapy.
Li Z; Xie QR; Chen Z; Lu S; Xia W
Lung Cancer; 2013 Oct; 82(1):9-15. PubMed ID: 23915912
[TBL] [Abstract][Full Text] [Related]
7. miR‑150 promotes the proliferation and migration of non‑small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.
Jiang K; Shen M; Chen Y; Xu W
Oncol Rep; 2018 Aug; 40(2):943-951. PubMed ID: 29901178
[TBL] [Abstract][Full Text] [Related]
8. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB
Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526
[TBL] [Abstract][Full Text] [Related]
9. MiR-520b promotes the progression of non-small cell lung cancer through activating Hedgehog pathway.
Liu X; Liu J; Zhang X; Tong Y; Gan X
J Cell Mol Med; 2019 Jan; 23(1):205-215. PubMed ID: 30407707
[TBL] [Abstract][Full Text] [Related]
10. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
11. E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation.
Liu L; Yu L; Zeng C; Long H; Duan G; Yin G; Dai X; Lin Z
Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932479
[TBL] [Abstract][Full Text] [Related]
12. Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover.
Zhang P; Gao K; Jin X; Ma J; Peng J; Wumaier R; Tang Y; Zhang Y; An J; Yan Q; Dong Y; Huang H; Yu L; Wang C
Cell Death Dis; 2015 Mar; 6(3):e1687. PubMed ID: 25766326
[TBL] [Abstract][Full Text] [Related]
13. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
Lu YJ; Liu RY; Hu K; Wang Y
Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
[TBL] [Abstract][Full Text] [Related]
14. Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation.
An J; Ren S; Murphy SJ; Dalangood S; Chang C; Pang X; Cui Y; Wang L; Pan Y; Zhang X; Zhu Y; Wang C; Halling GC; Cheng L; Sukov WR; Karnes RJ; Vasmatzis G; Zhang Q; Zhang J; Cheville JC; Yan J; Sun Y; Huang H
Mol Cell; 2015 Sep; 59(6):904-16. PubMed ID: 26344096
[TBL] [Abstract][Full Text] [Related]
15. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
Hoffmann G; Breitenbücher F; Schuler M; Ehrenhofer-Murray AE
J Biol Chem; 2014 Feb; 289(8):5208-16. PubMed ID: 24379401
[TBL] [Abstract][Full Text] [Related]
16. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
Su L; Han D; Wu J; Huo X
Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
[TBL] [Abstract][Full Text] [Related]
17. Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1.
Li C; Ao J; Fu J; Lee DF; Xu J; Lonard D; O'Malley BW
Oncogene; 2011 Oct; 30(42):4350-64. PubMed ID: 21577200
[TBL] [Abstract][Full Text] [Related]
18. CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer.
Wang J; Wang Y; Sun D; Ren F; Pang S; Xu S
Oncol Rep; 2017 May; 37(5):3068-3074. PubMed ID: 28405678
[TBL] [Abstract][Full Text] [Related]
19. CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features.
Elakoum R; Gauchotte G; Oussalah A; Wissler MP; Clément-Duchêne C; Vignaud JM; Guéant JL; Namour F
Biochimie; 2014 Feb; 97():210-8. PubMed ID: 24211191
[TBL] [Abstract][Full Text] [Related]
20. SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylase.
Zhu H; Ren S; Bitler BG; Aird KM; Tu Z; Skordalakes E; Zhu Y; Yan J; Sun Y; Zhang R
Cell Rep; 2015 Nov; 13(6):1183-1193. PubMed ID: 26527005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]